Recognition & Prestige CIS has recently earned notable awards such as being recognized as a top business in America and named the 2025 Best Research Center in Gurnee, IL, which can be leveraged to build credibility with prospective clients and investors seeking validated CRO/SMO partnerships.

Boutique Scale Advantage With 11-50 employees and a multi-site network focused on personalized attention, CIS positions itself as a nimble alternative to larger CROs, offering potentially faster decision cycles and tailored trial management for mid-sized pharma/biotech clients.

Comprehensive Service Model CIS blends CRO and SMO capabilities with hands-on research management, suggesting opportunities to upsell integrated services such as site management, patient engagement, and investigator coordination to streamline trials and improve outcomes.

Therapeutic Reach An extensive network of board-certified physicians across major therapeutic areas enables CIS to pitch multi-site, diverse patient enrollment strategies and rapid site activation to sponsors seeking broad trial reach.

Market Positioning Despite smaller scale, CIS’s emphasis on proactive value-added services and cutting-edge medicine, along with recent awards, can be used to target small-to-mid cap pharmaceutical and biotech firms seeking high-touch execution with visible quality signals.